Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers

  Chronic Renal Failure

  Free Subscription

Articles published in J Am Soc Nephrol

Retrieve available abstracts of 84 articles:
HTML format

Single Articles

    October 2021
  1. GARCIA P, Anand S, Han J, Montez-Rath M, et al
    COVID19 Vaccine Type and Humoral Immune Response in Patients Receiving Dialysis.
    J Am Soc Nephrol. 2021 Oct 13. pii: ASN.2021070936. doi: 10.1681/ASN.2021070936.

  2. LIOUFAS N, Pascoe E, Hawley C, Elder G, et al
    Systematic Review and Meta-analyses of Effects of Phosphate-lowering Agents in Non-dialysis Chronic Kidney Disease.
    J Am Soc Nephrol. 2021 Oct 13. pii: ASN.2021040554. doi: 10.1681/ASN.2021040554.
    PubMed     Abstract available

  3. NIU J, Saeed MK, Winkelmayer WC, Erickson KF, et al
    Patient Health Outcomes following Dialysis Facility Closures in the United States.
    J Am Soc Nephrol. 2021;32:2613-2621.
    PubMed     Abstract available

    September 2021
  4. VAN PRAET J, Reynders M, De Bacquer D, Viaene L, et al
    Predictors and Dynamics of the Humoral and Cellular Immune Response to SARS-CoV-2 mRNA Vaccines in Hemodialysis Patients: A Multicenter Observational Study.
    J Am Soc Nephrol. 2021 Sep 29. pii: ASN.2021070908. doi: 10.1681/ASN.2021070908.
    PubMed     Abstract available

  5. NIGRA AE, Navas-Acien A
    Racial Inequalities in Drinking Water Lead Exposure: A Wake-Up Call to Protect Patients with End Stage Kidney Disease.
    J Am Soc Nephrol. 2021 Sep 20. pii: ASN.2021060793. doi: 10.1681/ASN.2021060793.

  6. WETMORE J, Johansen K, Liu J, Peng Y, et al
    Changes in Treatment of Patients with Incident End-Stage Kidney Disease During the Novel Coronavirus Disease 2019 Pandemic.
    J Am Soc Nephrol. 2021 Sep 17. pii: ASN.2021040579. doi: 10.1681/ASN.2021040579.
    PubMed     Abstract available

  7. WEI S
    Long-Term Outcomes of Children Undergoing Dialysis-treated AKI: Some Opinions and Prospects.
    J Am Soc Nephrol. 2021 Sep 16. pii: ASN.2021060862. doi: 10.1681/ASN.2021060862.

  8. IDROVO A, Pignatelli R, Loar R, Nieuwsma A, et al
    Preserved Cerebral Oxygenation with Worsening Global Myocardial Strain during Pediatric Chronic Hemodialysis.
    J Am Soc Nephrol. 2021 Sep 13. pii: ASN.2021020193. doi: 10.1681/ASN.2021020193.
    PubMed     Abstract available

  9. CUKOR D, Zelnick L, Charytan D, Shallcross A, et al
    Patient Activation Measure in Dialysis Dependent Patients in the United States.
    J Am Soc Nephrol. 2021 Sep 1. pii: ASN.2021030315. doi: 10.1681/ASN.2021030315.

  10. MEYER TW, Blanco IJ, Grimm JC, Leypoldt JK, et al
    Barriers to Reducing Hemodialysis Time and Frequency in Patients with Residual Kidney Function.
    J Am Soc Nephrol. 2021;32:2112-2116.

    August 2021
  11. HEHER E, Elias N
    Addressing Transplant Candidacy When Evaluating Safety of Direct Oral Anticoagulant Agents in Patients on Hemodialysis.
    J Am Soc Nephrol. 2021 Aug 18. pii: ASN.2021060814. doi: 10.1681/ASN.2021060814.

  12. TUMMALAPALLI SL, Anderson G
    Comparative Health Care Spending for Dialysis: An Example of Public Cost Containment?
    J Am Soc Nephrol. 2021 Aug 16. pii: ASN.2021050694. doi: 10.1681/ASN.2021050694.
    PubMed     Abstract available

  13. POCKROS BM, Finch DJ, Weiner DE
    Dialysis and Total Health Care Costs in the United States and Worldwide: The Financial Impact of a Single-Payer Dominant System in the US.
    J Am Soc Nephrol. 2021 Aug 6. pii: ASN.2021010082. doi: 10.1681/ASN.2021010082.

  14. LACSON E, Argyropoulos C, Manley H, Aweh G, et al
    Immunogenicity of SARS-CoV-2 Vaccine in Dialysis.
    J Am Soc Nephrol. 2021 Aug 4. pii: ASN.2021040432. doi: 10.1681/ASN.2021040432.
    PubMed     Abstract available

  15. BANHAM GD, Godlee A, Faustini SE, Cunningham AF, et al
    Hemodialysis Patients Make Long-Lived Antibodies against SARS-CoV-2 that May Be Associated with Reduced Reinfection.
    J Am Soc Nephrol. 2021 Aug 2. pii: ASN.2021020188. doi: 10.1681/ASN.2021020188.

  16. WANG X, Grobe N, Patel A, Sharma S, et al
    Presence of SARS-CoV-2 Antibodies in Spent Peritoneal Dialysate.
    J Am Soc Nephrol. 2021;32:1865-1867.

  17. KRITMETAPAK K, Kumar R
    Novel Insights into Mechanisms of Intestinal Phosphate Absorption in Patients with Chronic Kidney Disease.
    J Am Soc Nephrol. 2021;32:1830-1832.

    July 2021
    Acquired Decline in Ultrafiltration in Peritoneal Dialysis: The Role of Glucose.
    J Am Soc Nephrol. 2021 Jul 28. pii: ASN.2021010080. doi: 10.1681/ASN.2021010080.
    PubMed     Abstract available

  19. WANG X, Grobe N, Haq Z, Thwin O, et al
    Testing of Worn Face Masks for Timely Diagnosis of SARS-CoV-2 in Hemodialysis Patients.
    J Am Soc Nephrol. 2021 Jul 19. pii: ASN.2021060812. doi: 10.1681/ASN.2021060812.
    PubMed     Abstract available

  20. PFAU A, Ermer T, Coca S, Tio M, et al
    High Oxalate Concentrations Correlate with Increased Risk for Sudden Cardiac Death in Dialysis Patients.
    J Am Soc Nephrol. 2021 Jul 19. pii: ASN.2020121793. doi: 10.1681/ASN.2020121793.
    PubMed     Abstract available

  21. CHERTOW G, Vart P, Jongs N, Toto R, et al
    Effects of Dapagliflozin in Stage 4 Chronic Kidney Disease.
    J Am Soc Nephrol. 2021 Jul 16. pii: ASN.2021020167. doi: 10.1681/ASN.2021020167.
    PubMed     Abstract available

  22. MYCHALECKYJ J, Valo E, Ichimura T, Ahluwalia T, et al
    Association of Coding Variants in Hydroxysteroid 17-beta Dehydrogenase 14 (HSD17B14) with Reduced Progression to End Stage Kidney Disease in Type 1 Diabetes.
    J Am Soc Nephrol. 2021 Jul 14. pii: ASN.2020101457. doi: 10.1681/ASN.2020101457.
    PubMed     Abstract available

  23. MADILL-THOMSEN K, Boehmig G, Bromberg J, Einecke G, et al
    Donor-Specific Antibody is Associated with Increased Expression of Rejection Transcripts in Renal Transplant Biopsies Classified As No Rejection.
    J Am Soc Nephrol. 2021 Jul 12. pii: ASN.2021040433. doi: 10.1681/ASN.2021040433.
    PubMed     Abstract available

  24. TAYLOR K, Crews D
    Toward Antiracist Reimbursement Policy in End-Stage Kidney Disease: From Equality to Equity.
    J Am Soc Nephrol. 2021 Jul 12. pii: ASN.2021020189. doi: 10.1681/ASN.2021020189.

  25. COHEN D, Sibbel S, Marlowe G, Bludorn K, et al
    Antibody Status, Disease History, and Incidence of SARS-CoV-2 Infection Among Patients on Chronic Dialysis.
    J Am Soc Nephrol. 2021 Jul 2. pii: ASN.2021030387. doi: 10.1681/ASN.2021030387.
    PubMed     Abstract available

    June 2021
  26. KOTSIS F, Schultheiss U, Wuttke M, Schlosser P, et al
    Self-Reported Medication Use and Urinary Drug Metabolites in the German Chronic Kidney Disease (GCKD) Study.
    J Am Soc Nephrol. 2021 Jun 17. pii: ASN.2021010063. doi: 10.1681/ASN.2021010063.
    PubMed     Abstract available

  27. WU S
    Correction: Long-term exposure to ambient PM2.5 and increased risk of chronic kidney disease prevalence in China.
    J Am Soc Nephrol. 2021 Jun 17. pii: ASN.2021050692. doi: 10.1681/ASN.2021050692.
    PubMed     Abstract available

  28. SATAKE E, Saulnier PJ, Kobayashi H, Gupta M, et al
    Comprehensive Search for Novel Circulating miRNAs and Axon Guidance Pathway Proteins Associated with Risk of End Stage Kidney Disease in Diabetes.
    J Am Soc Nephrol. 2021 Jun 17. pii: ASN.2021010105. doi: 10.1681/ASN.2021010105.
    PubMed     Abstract available

  29. JAIN N, Corken A, Kumar A, Davis C, et al
    Role of Platelets in Chronic Kidney Disease.
    J Am Soc Nephrol. 2021 Jun 17. pii: ASN.2020121806. doi: 10.1681/ASN.2020121806.
    PubMed     Abstract available

  30. DANTHU C, Hantz S, Dahlem A, Duval M, et al
    Humoral Response after SARS-Cov-2 mRNA Vaccine in a Cohort of Hemodialysis Patients and Kidney Transplant Recipients.
    J Am Soc Nephrol. 2021 Jun 16. pii: ASN.2021040490. doi: 10.1681/ASN.2021040490.
    PubMed     Abstract available

  31. ANAND S, Montez-Rath M, Han J, Garcia P, et al
    Antibody Response to COVID-19 Vaccination in Patients Receiving Dialysis.
    J Am Soc Nephrol. 2021 Jun 11. pii: ASN.2021050611. doi: 10.1681/ASN.2021050611.

  32. BERTRAND D, Hamzaoui M, Lemee V, Lamulle J, et al
    Antibody and T Cell Response to SARS-CoV-2 Messenger RNA BNT162b2 Vaccine in Kidney Transplant Recipients and Hemodialysis Patients.
    J Am Soc Nephrol. 2021 Jun 10. pii: ASN.2021040480. doi: 10.1681/ASN.2021040480.
    PubMed     Abstract available

  33. HSU CM, Weiner DE, Aweh G, Salenger P, et al
    Epidemiology and Outcomes of COVID-19 in Home Dialysis Patients Compared with In-Center Dialysis Patients.
    J Am Soc Nephrol. 2021 Jun 9. pii: ASN.2020111653. doi: 10.1681/ASN.2020111653.

  34. TUMMALAPALLI SL, Silberzweig J, Cukor D, Lin J, et al
    Racial and Neighborhood-level Disparities in COVID-19 Incidence Among Patients on Hemodialysis in New York City.
    J Am Soc Nephrol. 2021 Jun 3. pii: ASN.2020111606. doi: 10.1681/ASN.2020111606.
    PubMed     Abstract available

  35. WEINHANDL ED, Wetmore JB, Peng Y, Liu J, et al
    Initial Effects of COVID-19 on Patients with ESKD.
    J Am Soc Nephrol. 2021;32:1444-1453.
    PubMed     Abstract available

  36. MAYRDORFER M, Liefeldt L, Wu K, Rudolph B, et al
    Exploring the Complexity of Death-Censored Kidney Allograft Failure.
    J Am Soc Nephrol. 2021;32:1513-1526.
    PubMed     Abstract available

  37. LADIN K, Neckermann I, D'Arcangelo N, Koch-Weser S, et al
    Advance Care Planning in Older Adults with CKD: Patient, Care Partner, and Clinician Perspectives.
    J Am Soc Nephrol. 2021;32:1527-1535.
    PubMed     Abstract available

    May 2021
  38. GRENON E, Canet E
    High Incidence of Circuit Clotting in Critically-ill COVID-19 Patients Treated With Renal Replacement Therapy.
    J Am Soc Nephrol. 2021 May 28. pii: ASN.2021040528. doi: 10.1681/ASN.2021040528.

  39. ROBINSON C, Jeyakumar N, Luo B, Wald R, et al
    Long-term Kidney Outcomes Following Childhood Acute Kidney Injury Receiving Dialysis: A Population-based Cohort Study.
    J Am Soc Nephrol. 2021 May 26. pii: ASN.2020111665. doi: 10.1681/ASN.2020111665.
    PubMed     Abstract available

  40. RAMSPEK CL, Evans M, Wanner C, Drechsler C, et al
    Kidney Failure Prediction Models: A Comprehensive External Validation Study in Patients with Advanced CKD.
    J Am Soc Nephrol. 2021;32:1174-1186.
    PubMed     Abstract available

    April 2021
  41. GARCIA P, Montez-Rath ME, Moore H, Flotte J, et al
    SARS-CoV-2 Vaccine Acceptability in Patients on Hemodialysis: A Nationwide Survey.
    J Am Soc Nephrol. 2021 Apr 29. pii: ASN.2021010104. doi: 10.1681/ASN.2021010104.
    PubMed     Abstract available

  42. TANGRI N, Garg AX, Ferguson TW, Dixon S, et al
    Effects of a Knowledge-Translation Intervention on Early Dialysis Initiation: A Cluster Randomized Trial.
    J Am Soc Nephrol. 2021 Apr 15. pii: ASN.2020091254. doi: 10.1681/ASN.2020091254.
    PubMed     Abstract available

    March 2021
  43. PERGOLA PE, Rosenbaum DP, Yang Y, Chertow GM, et al
    A Randomized Trial of Tenapanor and Phosphate Binders as a Dual-Mechanism Treatment for Hyperphosphatemia in Patients on Maintenance Dialysis (AMPLIFY).
    J Am Soc Nephrol. 2021 Mar 25. pii: ASN.2020101398. doi: 10.1681/ASN.2020101398.
    PubMed     Abstract available

  44. DE VRIESE AS, Caluwe R, Van Der Meersch H, De Boeck K, et al
    Safety and Efficacy of Vitamin K Antagonists versus Rivaroxaban in Hemodialysis Patients with Atrial Fibrillation: A Multicenter Randomized Controlled Trial.
    J Am Soc Nephrol. 2021 Mar 22. pii: ASN.2020111566. doi: 10.1681/ASN.2020111566.
    PubMed     Abstract available

  45. CHERIF A, Willetts JL, Usvyat L, Wang Y, et al
    Comparative Analysis of SARS-CoV-2 Reproduction Rates in the Dialysis and General Populations.
    J Am Soc Nephrol. 2021 Mar 8. pii: ASN.2020121691. doi: 10.1681/ASN.2020121691.

  46. LIU F, Wang J, Ye Q, Fu H, et al
    Roxadustat for Renal Anemia in ESRD from PKD Patients: Is It Safe Enough?
    J Am Soc Nephrol. 2021 Mar 1. pii: ASN.2020111664. doi: 10.1681/ASN.2020111664.

  47. KU E, McCulloch CE, Adey DB, Li L, et al
    Racial Disparities in Eligibility for Preemptive Waitlisting for Kidney Transplantation and Modification of eGFR Thresholds to Equalize Waitlist Time.
    J Am Soc Nephrol. 2021;32:677-685.
    PubMed     Abstract available

  48. RAVINDRAN A, Casal Moura M, Fervenza FC, Nasr SH, et al
    In Patients with Membranous Lupus Nephritis, Exostosin-Positivity and Exostosin-Negativity Represent Two Different Phenotypes.
    J Am Soc Nephrol. 2021;32:695-706.
    PubMed     Abstract available

    February 2021
  49. SAKHI H, Dahmane D, Attias P, Kofman T, et al
    Kinetics of Anti-SARS-CoV-2 IgG Antibodies in Hemodialysis Patients Six Months after Infection.
    J Am Soc Nephrol. 2021 Feb 26. pii: ASN.2020111618. doi: 10.1681/ASN.2020111618.
    PubMed     Abstract available

  50. KLIGER AS, Silberzweig J
    COVID-19 and Dialysis Patients: Unsolved Problems in Early 2021.
    J Am Soc Nephrol. 2021 Feb 26. pii: ASN.2020121766. doi: 10.1681/ASN.2020121766.

  51. FISHBANE S, El-Shahawy MA, Pecoits-Filho R, Van BP, et al
    Roxadustat for Treating Anemia in Patients with CKD Not on Dialysis: Results from a Randomized Phase 3 Study.
    J Am Soc Nephrol. 2021 Feb 10. pii: ASN.2020081150. doi: 10.1681/ASN.2020081150.
    PubMed     Abstract available

  52. ISAKA Y, Hamano T, Fujii H, Tsujimoto Y, et al
    Optimal Phosphate Control Related to Coronary Artery Calcification in Dialysis Patients.
    J Am Soc Nephrol. 2021 Feb 5. pii: ASN.2020050598. doi: 10.1681/ASN.2020050598.
    PubMed     Abstract available

  53. SUMIDA K, Dashputre AA, Potukuchi PK, Thomas F, et al
    Laxative Use and Risk of Dyskalemia in Patients with Advanced CKD Transitioning to Dialysis.
    J Am Soc Nephrol. 2021 Feb 5. pii: ASN.2020081120. doi: 10.1681/ASN.2020081120.
    PubMed     Abstract available

  54. CANNEY M, Barbour SJ, Zheng Y, Coppo R, et al
    Quantifying Duration of Proteinuria Remission and Association with Clinical Outcome in IgA Nephropathy.
    J Am Soc Nephrol. 2021;32:436-447.
    PubMed     Abstract available

  55. AHLENSTIEL-GRUNOW T, Liu X, Schild R, Oh J, et al
    Steering Transplant Immunosuppression by Measuring Virus-Specific T Cell Levels: The Randomized, Controlled IVIST Trial.
    J Am Soc Nephrol. 2021;32:502-516.
    PubMed     Abstract available

  56. CALDERON-MARGALIT R, Pleniceanu O, Tzur D, Stern-Zimmer M, et al
    Childhood Cancer and the Risk of ESKD.
    J Am Soc Nephrol. 2021;32:495-501.
    PubMed     Abstract available

  57. REHNBERG J, Symreng A, Ludvigsson JF, Emilsson L, et al
    Inflammatory Bowel Disease Is More Common in Patients with IgA Nephropathy and Predicts Progression of ESKD: A Swedish Population-Based Cohort Study.
    J Am Soc Nephrol. 2021;32:411-423.
    PubMed     Abstract available

    January 2021
  58. ZHENG Z, Waikar SS, Schmidt IM, Landis JR, et al
    Subtyping CKD Patients by Consensus Clustering: The Chronic Renal Insufficiency Cohort (CRIC) Study.
    J Am Soc Nephrol. 2021 Jan 18. pii: ASN.2020030239. doi: 10.1681/ASN.2020030239.
    PubMed     Abstract available

  59. HSU S, Zelnick LR, Lin YS, Best CM, et al
    Differences in 25-Hydroxyvitamin D Clearance by eGFR and Race: A Pharmacokinetic Study.
    J Am Soc Nephrol. 2021;32:188-198.
    PubMed     Abstract available

  60. KELLY JT, Su G, Zhang, Qin X, et al
    Modifiable Lifestyle Factors for Primary Prevention of CKD: A Systematic Review and Meta-Analysis.
    J Am Soc Nephrol. 2021;32:239-253.
    PubMed     Abstract available

    December 2020
  61. REDDY YNV, Tummalapalli SL, Mendu ML
    Ensuring the Equitable Advancement of American Kidney Health-the Need to Account for Socioeconomic Disparities in the ESRD Treatment Choices Model.
    J Am Soc Nephrol. 2020 Dec 30. pii: ASN.2020101466. doi: 10.1681/ASN.2020101466.

  62. PERGOLA PE, Devalaraja M, Fishbane S, Chonchol M, et al
    Ziltivekimab for Treatment of Anemia of Inflammation in Patients on Hemodialysis: Results from a Phase 1/2 Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial.
    J Am Soc Nephrol. 2020 Dec 3. pii: ASN.2020050595. doi: 10.1681/ASN.2020050595.
    PubMed     Abstract available

  63. PALZER EF, Vempati S, Helgeson ES, Matas AJ, et al
    Long-Term Living Kidney Donor Risk: A Web-Based Calculator.
    J Am Soc Nephrol. 2020;31:2968-2969.

    November 2020
  64. CASAL MOURA M, Irazabal MV, Eirin A, Zand L, et al
    Efficacy of Rituximab and Plasma Exchange in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis with Severe Kidney Disease.
    J Am Soc Nephrol. 2020;31:2688-2704.
    PubMed     Abstract available

  65. O'HARE AM, Butler CR, Taylor JS, Wong SPY, et al
    Thematic Analysis of Hospice Mentions in the Health Records of Veterans with Advanced Kidney Disease.
    J Am Soc Nephrol. 2020;31:2667-2677.
    PubMed     Abstract available

    October 2020
  66. SCHRAUBEN SJ, Shou H, Zhang X, Anderson AH, et al
    Association of Multiple Plasma Biomarker Concentrations with Progression of Prevalent Diabetic Kidney Disease: Findings from the Chronic Renal Insufficiency Cohort (CRIC) Study.
    J Am Soc Nephrol. 2020 Oct 29. pii: ASN.2020040487. doi: 10.1681/ASN.2020040487.
    PubMed     Abstract available

  67. CHAZOT G, Lemoine S, Kocevar G, Kalbacher E, et al
    Intracellular Phosphate and ATP Depletion Measured by Magnetic Resonance Spectroscopy in Patients Receiving Maintenance Hemodialysis.
    J Am Soc Nephrol. 2020 Oct 22. pii: ASN.2020050716. doi: 10.1681/ASN.2020050716.
    PubMed     Abstract available

  68. WEISS S, Bhat P, Del Pilar Fernandez M, Bhat JG, et al
    COVID-19 Infection in ESKD: Findings from a Prospective Disease Surveillance Program at Dialysis Facilities in New York City and Long Island.
    J Am Soc Nephrol. 2020 Oct 19. pii: ASN.2020070932. doi: 10.1681/ASN.2020070932.

  69. GUPTA S, Coca SG, Chan L, Melamed ML, et al
    AKI Treated with Renal Replacement Therapy in Critically Ill Patients with COVID-19.
    J Am Soc Nephrol. 2020 Oct 16. pii: ASN.2020060897. doi: 10.1681/ASN.2020060897.
    PubMed     Abstract available

  70. LEPPING RJ, Montgomery RN, Sharma P, Mahnken JD, et al
    Normalization of Cerebral Blood Flow, Neurochemicals, and White Matter Integrity after Kidney Transplantation.
    J Am Soc Nephrol. 2020 Oct 16. pii: ASN.2020050584. doi: 10.1681/ASN.2020050584.
    PubMed     Abstract available

  71. KING KL, Husain SA, Schold JD, Patzer RE, et al
    Major Variation across Local Transplant Centers in Probability of Kidney Transplant for Wait-Listed Patients.
    J Am Soc Nephrol. 2020 Oct 9. pii: ASN.2020030335. doi: 10.1681/ASN.2020030335.
    PubMed     Abstract available

  72. COFFMAN TM, Chan CM, Choong LH, Curran I, et al
    Perspectives on COVID-19 from Singapore: Impact on ESKD Care and Medical Education.
    J Am Soc Nephrol. 2020;31:2242-2245.

  73. DANZIGER J, Angel Armengol de la Hoz M, Celi LA, Cohen RA, et al
    Use of Do-Not-Resuscitate Orders for Critically Ill Patients with ESKD.
    J Am Soc Nephrol. 2020;31:2393-2399.
    PubMed     Abstract available

  74. OSHIMA M, Neal B, Toyama T, Ohkuma T, et al
    Different eGFR Decline Thresholds and Renal Effects of Canagliflozin: Data from the CANVAS Program.
    J Am Soc Nephrol. 2020;31:2446-2456.
    PubMed     Abstract available

    September 2020
  75. RODRIGUEZ-ESPINOSA D, Broseta JJ, Cuadrado E, Maduell F, et al
    Prevalence of COVID-19 Infection in Hemodialysis Patients Detected Using Serologic Screening.
    J Am Soc Nephrol. 2020 Sep 29. pii: ASN.2020081193. doi: 10.1681/ASN.2020081193.

  76. RAHMAN M, Wang X, Bundy JD, Charleston J, et al
    Prognostic Significance of Ambulatory BP Monitoring in CKD: A Report from the Chronic Renal Insufficiency Cohort (CRIC) Study.
    J Am Soc Nephrol. 2020 Sep 24. pii: ASN.2020030236. doi: 10.1681/ASN.2020030236.
    PubMed     Abstract available

  77. KHAIRALLAH P, Kudose S, Morris HK, Ratner LE, et al
    Reversal of Donor Hepatitis C Virus-Related Mesangial Proliferative GN in a Kidney Transplant Recipient.
    J Am Soc Nephrol. 2020 Sep 16. pii: ASN.2020060820. doi: 10.1681/ASN.2020060820.

  78. BUTLER CR, Reese PP, Perkins JD, Hall YN, et al
    End-of-Life Care among US Adults with ESKD in the United States Who Were Waitlisted or Received a Kidney Transplant, 2005-2014.
    J Am Soc Nephrol. 2020 Sep 9. pii: ASN.2020030342. doi: 10.1681/ASN.2020030342.
    PubMed     Abstract available

  79. RAYEGO-MATEOS S, Morgado-Pascual JL, Valdivielso JM, Sanz AB, et al
    TRAF3 Modulation: Novel Mechanism for the Anti-inflammatory Effects of the Vitamin D Receptor Agonist Paricalcitol in Renal Disease.
    J Am Soc Nephrol. 2020;31:2026-2042.
    PubMed     Abstract available

    August 2020
  80. ELIAS M, Pievani D, Randoux C, Louis K, et al
    COVID-19 Infection in Kidney Transplant Recipients: Disease Incidence and Clinical Outcomes.
    J Am Soc Nephrol. 2020 Aug 26. pii: ASN.2020050639. doi: 10.1681/ASN.2020050639.
    PubMed     Abstract available

    July 2020
  81. LOUIS K, Macedo C, Bailly E, Lau L, et al
    Coordinated Circulating T Follicular Helper and Activated B Cell Responses Underlie the Onset of Antibody-Mediated Rejection in Kidney Transplantation.
    J Am Soc Nephrol. 2020 Jul 28. pii: ASN.2020030320. doi: 10.1681/ASN.2020030320.
    PubMed     Abstract available

    May 2020
  82. COYNE DW, Fishbane S
    The Value of Intravenous Iron: Beyond the Cave of Speculation.
    J Am Soc Nephrol. 2020;31:896-897.

    March 2020
  83. JACQUEMONT L, Tilly G, Yap M, Doan-Ngoc TM, et al
    Terminally Differentiated Effector Memory CD8(+) T Cells Identify Kidney Transplant Recipients at High Risk of Graft Failure.
    J Am Soc Nephrol. 2020 Mar 12. pii: ASN.2019080847. doi: 10.1681/ASN.2019080847.
    PubMed     Abstract available

  84. MENDU ML, Tummalapalli SL, Lentine KL, Erickson KF, et al
    Measuring Quality in Kidney Care: An Evaluation of Existing Quality Metrics and Approach to Facilitating Improvements in Care Delivery.
    J Am Soc Nephrol. 2020;31:602-614.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Chronic Renal Failure is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.